proxyvotesnow.com

Home › Asset managers › Nationwide › 2024-2025 › Against the board

Nationwide 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Nationwide voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

5,709 proposals.

Nationwide, 2024-2025 proxy season. Who put a proposal on the ballot is taken from its N-PX category; see the method note on the overview page.
CompanyMeetingProposalCategory On the ballot fromNationwide votedFunds
Truist Financial Corporation 2025-04-29 Advisory vote to approve Truist's executive compensation program. Say-on-Pay Board AGAINST 3
UniCredit SpA 2025-03-27 Approve 2025 Group Incentive System Compensation Board AGAINST 3
UniCredit SpA 2025-03-27 Approve Remuneration Policy Compensation Board AGAINST 3
UniCredit SpA 2025-03-27 Approve Second Section of the Remuneration Report Compensation Board AGAINST 3
UniCredit SpA 2025-03-27 Authorize Board to Increase Capital to Service the 2024 Group Incentive System Compensation Board AGAINST 3
United Parks & Resorts Inc. 2025-06-13 To elect the ten director nominees: Kimberly Schaefer Director Elections Board AGAINST 3
United Parks & Resorts Inc. 2025-06-13 To elect the ten director nominees: Neha Jogani Narang Director Elections Board AGAINST 3
United States Lime & Minerals, Inc. 2025-05-02 To approve on a non-binding advisory basis, the Company's executive compensation. Say-on-Pay Board AGAINST 3
UnitedHealth Group Incorporated 2025-06-02 Election of Directors: John Noseworthy, M.D. Director Elections Board AGAINST 3
Universal Music Group NV 2025-05-14 Reelect Sherry Lansing as Non-Executive Director Director Elections Board AGAINST 3
Upstart Holdings, Inc. 2025-05-23 The approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay Board AGAINST 3
Vale SA 2025-04-30 Amend Long-Term Incentive Plan Compensation Board AGAINST 3
Village Super Market, Inc. 2024-12-13 Election of Directors: John J. Sumas Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: John P. Sumas Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Kevin Begley Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Nicholas Sumas Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Perry Blatt Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Prasad Pola Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Robert Sumas Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Stephen F. Rooney Director Elections Board ABSTAIN 3
Village Super Market, Inc. 2024-12-13 Election of Directors: Steven Crystal Director Elections Board ABSTAIN 3
VirTra, Inc. 2024-10-21 Election of Directors: Gregg C.E. Johnson Director Elections Board ABSTAIN 3
VirTra, Inc. 2024-10-21 Election of Directors: Jeffrey D. Brown Director Elections Board ABSTAIN 3
Warby Parker Inc. 2025-06-10 Election of Directors: Jeffrey Raider Director Elections Board ABSTAIN 3
Wells Fargo & Company 2025-04-29 Shareholder Proposal - Energy Supply Ratio. Environment or Climate Shareholder FOR 3
Western Digital Corporation 2024-11-20 Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement. Say-on-Pay Board AGAINST 3
Westpac Banking Corporation 2024-12-13 Elect Margaret Seale as Director Director Elections Board AGAINST 3
Whitestone REIT 2025-05-15 To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation Board AGAINST 3
Woolworths Group Limited 2024-10-31 Approve Conditional Spill Resolution Compensation Board AGAINST 3
Woolworths Group Limited 2024-10-31 Elect Maxine Brenner as Director Director Elections Board AGAINST 3
Worthington Enterprises, Inc. 2024-09-24 Approve the Worthington Enterprises, Inc. 2024 Long-Term Incentive Plan. Compensation Board AGAINST 3
Xero Limited 2024-08-22 Approve Remuneration Report Compensation Board AGAINST 3
agilon health, inc. 2025-05-28 Election of Class I Directors: Sharad Mansukani, M.D. Director Elections Board AGAINST 3
e.l.f. Beauty, Inc. 2024-08-22 To elect three Class II directors to serve a three-year term expiring at our 2027 annual meeting of stockholders: Tiffany Daniele Director Elections Board ABSTAIN 3
eBay Inc. 2025-06-25 Advisory vote to approve named executive officer compensation. Say-on-Pay Board AGAINST 3
iTeos Therapeutics, Inc. 2025-06-17 Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Tony Ho Director Elections Board ABSTAIN 3
1stdibs.com, Inc. 2025-05-08 The election of three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: David S. Rosenblatt Director Elections Board ABSTAIN 2
23andMe Holding Co. 2024-08-26 Elect two Class III Director Nominees: Anne Wojcicki Director Elections Board ABSTAIN 2
23andMe Holding Co. 2024-08-26 Elect two Class III Director Nominees: Peter Taylor Director Elections Board ABSTAIN 2
374Water Inc. 2025-06-11 Election of Directors: James M. Vanderhider Director Elections Board ABSTAIN 2
3D Systems Corporation 2025-05-16 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections Board AGAINST 2
3D Systems Corporation 2025-05-16 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections Board AGAINST 2
89bio, Inc. 2025-05-28 Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. Director Elections Board ABSTAIN 2
89bio, Inc. 2025-05-28 Election of Directors: To be elected for terms expiring in 2028: Martin Babler Director Elections Board ABSTAIN 2
8x8, Inc. 2024-08-15 To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. Compensation Board AGAINST 2
A-Mark Precious Metals, Inc. 2024-11-13 To vote, on an advisory basis, to approve the fiscal year 2024 compensation of the named executive officers of the Company. Say-on-Pay Board AGAINST 2
A. O. Smith Corporation 2025-04-08 Election of directors: Michael M. Larsen Director Elections Board ABSTAIN 2
A. O. Smith Corporation 2025-04-08 Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation: Audit-related Board AGAINST 2
A.P. Moller-Maersk A/S 2025-03-18 Reelect Marc Engel as Director Director Elections Board ABSTAIN 2
AAON, Inc. 2025-05-13 Election of Directors for a term ending in 2028: A.H. McElroy, II Director Elections Board AGAINST 2
ACS, Actividades de Construccion y Servicios SA 2025-05-08 Reelect Jose Eladio Seco Dominguez as Director Director Elections Board AGAINST 2
ADC Therapeutics SA 2024-11-11 Approving amendments to Article 4a of the articles of association to increase the Company's capital range The Board of Directors proposes that the amendments to Article 4a of the articles of association to increase the Company's capital range be approved. Capital Structure Board AGAINST 2
ADC Therapeutics SA 2024-11-11 Approving amendments to Article 4c of the articles of association to Increase the Company's conditional share capital for financing, acquisitions and other purposes The Board of Directors proposes that the amendments to Article 4c of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes be approved. Capital Structure Board AGAINST 2
ADC Therapeutics SA 2025-06-03 Approving amendments to article 4b of the articles of association to increase the Company's conditional share capital for employee participation The Board of Directors is proposing that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,547,482 common shares (CHF 763,798.56) to 12,776,259 common shares (CHF 1,022,100.72) be approved, as follows (amendment underlined for ease of reference): "The share capital may be increased in an amount not to exceed CHF 1,022,100.72 through the issuance of up to 12,776,259 fully paid in registered shares with a par value of CHF 0.08 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares, which were granted to or imposed on members of the Board of Directors, members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies." Capital Structure Board AGAINST 2
ADC Therapeutics SA 2025-06-03 Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors is proposing that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. Compensation Board AGAINST 2
ADC Therapeutics SA 2025-06-03 Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2026 annual general meeting of Shareholders be set at $2,300,000. Compensation Board AGAINST 2
ADMA Biologics, Inc. 2025-06-04 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
AMC Networks Inc. 2025-06-05 Advisory vote on Named Executive Officer compensation Say-on-Pay Board AGAINST 2
AMC Networks Inc. 2025-06-05 Vote on Proposal to Approve the Company's Redomestication to the State of Nevada by Conversion Extraordinary Transactions Board AGAINST 2
AMERICA'S CAR-MART, INC. 2024-08-27 To approve the America's Car-Mart, Inc. 2024 Equity Incentive Plan. Compensation Board AGAINST 2
AMN HEALTHCARE SERVICES, INC. 2025-05-02 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay Board AGAINST 2
APA CORPORATION 2025-05-22 Advisory Vote to Approve Compensation of APA's Named Executive Officers Say-on-Pay Board AGAINST 2
APA Group 2024-10-24 Approve Conditional Spill Resolution Compensation Board AGAINST 2
ASP Isotopes Inc. 2024-11-20 Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, as amended. Compensation Board AGAINST 2
ASP Isotopes Inc. 2024-11-20 Election of directors to serve as Class II directors for a three-year term: Duncan Moore, Ph.D. Director Elections Board ABSTAIN 2
ASP Isotopes Inc. 2024-11-20 Election of directors to serve as Class II directors for a three-year term: Michael Gorley, Ph.D. Director Elections Board ABSTAIN 2
AST Spacemobile, Inc. 2024-09-10 To approve the AST SpaceMobile, Inc. 2024 Incentive Award Plan. Compensation Board AGAINST 2
AST Spacemobile, Inc. 2024-09-10 To elect ten directors to the Company's Board of Directors for a term expiring at the Company's 2025 Annual Meeting of Stockholders: Abel Avellan Director Elections Board ABSTAIN 2
ASX Limited 2024-10-28 Approve Remuneration Report Compensation Board AGAINST 2
ASX Limited 2024-10-28 Elect Philip Galvin as Director Director Elections Board AGAINST 2
ASX Limited 2024-10-28 Elect Robert Caisley as Director Director Elections Board AGAINST 2
ATI Inc. 2025-05-16 Election of Directors: Carolyn Corvi Director Elections Board ABSTAIN 2
AbbVie Inc. 2025-05-09 Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay Board AGAINST 2
Abbott Laboratories 2025-04-25 Election of 12 Directors: J. G. Stratton Director Elections Board AGAINST 2
Abbott Laboratories 2025-04-25 Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay Board AGAINST 2
Acadia Healthcare Company, Inc. 2025-05-29 Election of Directors: Reeve B. Waud Director Elections Board AGAINST 2
Acciona SA 2025-06-25 Advisory Vote on Remuneration Report Compensation Board AGAINST 2
Acciona SA 2025-06-25 Approve Remuneration Policy Compensation Board AGAINST 2
Acciona SA 2025-06-25 Reelect Carlo Clavarino as Director Director Elections Board AGAINST 2
Acciona SA 2025-06-25 Reelect Maite Arango Garcia-Urtiaga as Director Director Elections Board AGAINST 2
Accolade, Inc. 2024-08-06 Election of Directors: Cindy Kent Director Elections Board ABSTAIN 2
Accor SA 2025-05-28 Reelect Nicolas Sarkozy as Director Director Elections Board AGAINST 2
Accton Technology Corp. 2025-06-12 Elect a Representative of Golden Tengis Co., Ltd, with Shareholder No. 192057, as Non-independent Director Director Elections Board AGAINST 2
Achieve Life Sciences, Inc. 2025-06-04 To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. Compensation Board AGAINST 2
Acrivon Therapeutics, Inc. 2025-06-13 Election of Class III Directors: Derek DiRocco, Ph.D. Director Elections Board ABSTAIN 2
Acushnet Holdings Corp. 2025-06-02 Election of the following nominees for director: Yoon Soo (Gene) Yoon Director Elections Board ABSTAIN 2
AdaptHealth Corp. 2025-06-18 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Terence Connors Director Elections Board ABSTAIN 2
Adobe Inc. 2025-04-22 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending on November 28, 2025. Audit-related Board AGAINST 2
Advanced Micro Devices, Inc. 2025-05-14 Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the current fiscal year. Audit-related Board AGAINST 2
Adverum Biotechnologies, Inc. 2025-06-17 To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. Compensation Board AGAINST 2
Aeva Technologies, Inc. 2025-06-20 Election of Class I Directors: Stefan Sommer, Ph. D. Director Elections Board ABSTAIN 2
Aflac Incorporated 2025-05-05 to consider and act upon the ratification of the appointment of KPMG LLP as independent registered public accounting firm of the Company for the year ending December 31, 2025 Audit-related Board AGAINST 2
Agenus Inc. 2025-06-17 To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. Compensation Board AGAINST 2
Agenus Inc. 2025-06-17 To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Agilent Technologies, Inc. 2025-03-13 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. Audit-related Board AGAINST 2
Air Transport Services Group, Inc. 2025-02-10 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"); and Say-on-Pay Board AGAINST 2
Aisin Corp. 2025-06-17 Elect Director Kobayashi, Koji Director Elections Board AGAINST 2
Akamai Technologies, Inc. 2025-05-14 To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2025. Audit-related Board AGAINST 2
Aker BP ASA 2025-05-13 Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights Capital Structure Board AGAINST 2
Aker BP ASA 2025-05-13 Approve Remuneration Statement Compensation Board AGAINST 2

← Previous Page 9 of 58 Next →

← Back to Nationwide 2024-2025 overview

Built 2026-10-04 from SEC Form N-PX filings.